AMYRIS TO PARTICIPATE AT SEPTEMBER INVESTOR CONFERENCES
Amyris, Inc. (Nasdaq: AMRS), a leader in synthetic biotechnology focused on sustainable consumer products, announced its participation in two investor conferences.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Amyris, Inc. (Nasdaq: AMRS), a leader in synthetic biotechnology focused on sustainable consumer products, announced its participation in two investor conferences. The company will engage in fireside chats moderated by equity research analysts, providing updates on its operations. Key events include the H.C. Wainwright 24th Annual Global Investment Conference on September 12 at 7:00 AM ET (virtual) and the Piper Sandler Growth Frontiers Conference on September 13 at 3:30 PM CT (in-person, Nashville, TN). Live webcasts and replays of these presentations will be available on Amyris' Investor Relations website.
Details
News Market Reaction – AMRS
The recorded move for AMRS in the trading session of this news was +19.56%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
EMERYVILLE, Calif., Sept. 7, 2022 /PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company accelerating the world's transition to sustainable consumption through its Lab-to-Market™ technology platform and clean beauty consumer brands, today announced that management will participate in fireside chats moderated by equity research analysts, and provide updates, at two upcoming investor conferences:
- H.C. Wainwright 24th Annual Global Investment Conference, Monday, September 12 at 7:00 AM ET (virtual)
- Piper Sandler Growth Frontiers Conference, Tuesday, September 13 at 3:30 PM CT/ 4:30 PM ET (in-person at Nashville, TN)
Live webcasts of the presentations and replays will be available on the Investor Relations section of the company's website at https://investors.amyris.com/events-and-presentations.
Amyris (Nasdaq: AMRS) is a leading synthetic biotechnology company, transitioning the Clean Health & Beauty and Flavors & Fragrances markets to sustainable ingredients through fermentation and the company's proprietary Lab-to-Market™ technology platform. This Amyris platform leverages state-of-the-art machine learning, robotics and artificial intelligence, enabling the company to rapidly bring new innovation to market at commercial scale. Amyris ingredients are included in over 20,000 products from the world's top brands, reaching more than 300 million consumers. Amyris also owns and operates a family of consumer brands that is constantly evolving to meet the growing demand for sustainable, effective and accessible products. For more information, please visit http://www.amyris.com.
Amyris, the Amyris logo, and Lab-to-Market, are trademarks or registered trademarks of Amyris, Inc. or its subsidiaries in the U.S. and/or other countries.
View original content to download multimedia:https://www.prnewswire.com/news-releases/amyris-to-participate-at-september-investor-conferences-301618747.html
SOURCE Amyris, Inc.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.